Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17,119 | -$98,181 | -$50,790 | -$34,705 |
| Dep. & Amort. | $2,561 | $3,318 | $3,860 | $2,036 |
| Deferred Tax | -$2,237 | -$13,503 | -$3,526 | -$820 |
| Stock-Based Comp. | $266 | $814 | $2,186 | $1,143 |
| Change in WC | $2,679 | -$991 | $5,592 | -$5,234 |
| Other Non-Cash | $10,934 | $90,931 | $18,570 | $1,869 |
| Operating Cash Flow | -$2,916 | -$17,612 | -$24,108 | -$35,711 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$446 | -$521 | -$13,708 |
| Net Acquisitions | $0 | $0 | -$7,920 | -$16,670 |
| Inv. Purchases | $0 | -$5 | -$38 | -$23 |
| Inv. Sales/Matur. | $2 | $0 | $462 | $132 |
| Other Inv. Act. | $4,413 | $9,146 | $0 | -$13,581 |
| Investing Cash Flow | $4,401 | $8,695 | -$8,017 | -$30,269 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$346 | -$550 | -$471 | -$5,551 |
| Stock Issued | $0 | $5,094 | $7,111 | $76,088 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$516 | -$494 | -$223 | -$2,848 |
| Financing Cash Flow | -$862 | $4,050 | $6,417 | $67,689 |
| Forex Effect | -$99 | $186 | $184 | -$102 |
| Net Chg. in Cash | $524 | -$4,681 | -$25,524 | $1,607 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,556 | $19,237 | $44,761 | $43,154 |
| End Cash | $15,080 | $14,556 | $19,237 | $44,761 |
| Free Cash Flow | -$3,088 | -$18,058 | -$24,629 | -$49,419 |